Cargando…
Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366321/ https://www.ncbi.nlm.nih.gov/pubmed/28396667 http://dx.doi.org/10.3389/fimmu.2017.00342 |
_version_ | 1782517568223838208 |
---|---|
author | Yolcu, Esma S. Shirwan, Haval Askenasy, Nadir |
author_facet | Yolcu, Esma S. Shirwan, Haval Askenasy, Nadir |
author_sort | Yolcu, Esma S. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5366321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53663212017-04-10 Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes Yolcu, Esma S. Shirwan, Haval Askenasy, Nadir Front Immunol Immunology Frontiers Media S.A. 2017-03-27 /pmc/articles/PMC5366321/ /pubmed/28396667 http://dx.doi.org/10.3389/fimmu.2017.00342 Text en Copyright © 2017 Yolcu, Shirwan and Askenasy. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Yolcu, Esma S. Shirwan, Haval Askenasy, Nadir Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes |
title | Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes |
title_full | Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes |
title_fullStr | Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes |
title_full_unstemmed | Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes |
title_short | Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes |
title_sort | fas/fas-ligand interaction as a mechanism of immune homeostasis and β-cell cytotoxicity: enforcement rather than neutralization for treatment of type 1 diabetes |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366321/ https://www.ncbi.nlm.nih.gov/pubmed/28396667 http://dx.doi.org/10.3389/fimmu.2017.00342 |
work_keys_str_mv | AT yolcuesmas fasfasligandinteractionasamechanismofimmunehomeostasisandbcellcytotoxicityenforcementratherthanneutralizationfortreatmentoftype1diabetes AT shirwanhaval fasfasligandinteractionasamechanismofimmunehomeostasisandbcellcytotoxicityenforcementratherthanneutralizationfortreatmentoftype1diabetes AT askenasynadir fasfasligandinteractionasamechanismofimmunehomeostasisandbcellcytotoxicityenforcementratherthanneutralizationfortreatmentoftype1diabetes |